Increased survival after gemfibrozil treatment of severe mouse influenza.
about
The influenza virus enigmaModulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory DrugsCompounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virusMeeting the challenge of influenza pandemic preparedness in developing countriesThe pharmacological management of severe influenza infection - 'existing and emerging therapies'.Adjunctive therapies and immunomodulating agents for severe influenza.Augmented lung inflammation protects against influenza A pneumonia.Interplay between influenza A virus and host factors: targets for antiviral intervention.Confronting the next influenza pandemic with anti-inflammatory and immunomodulatory agents: why they are needed and how they might work.Drugs in development for influenza.Peroxisome proliferator-activated receptor and AMP-activated protein kinase agonists protect against lethal influenza virus challenge in mice.Combinations of L-NG-monomethyl-arginine and oseltamivir against pandemic influenza A virus infections in mice.Preventing and treating secondary bacterial infections with antiviral agentsThe controversy over H5N1 transmissibility research: an opportunity to define a practical response to a global threatNewer influenza antivirals, biotherapeutics and combinations.Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus.Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology.Using Complementary and Alternative Medicines to Target the Host Response during Severe Influenza.How to approach and treat viral infections in ICU patientsVirus infection rapidly activates the P58(IPK) pathway, delaying peak kinase activation to enhance viral replication.Chemical and protein structural basis for biological crosstalk between PPARα and COX enzymes.Into the eye of the cytokine storm.In vitro antimalarial activity and drug interactions of fenofibric acidThe cytokine storm of severe influenza and development of immunomodulatory therapyDietary abscisic acid ameliorates influenza-virus-associated disease and pulmonary immunopathology through a PPARγ-dependent mechanism.Effect of statin treatments on highly pathogenic avian influenza H5N1, seasonal and H1N1pdm09 virus infections in BALB/c miceInvited commentary on David Fedson's articleAlong a TNF-paved road from dead parasites in red cells to cerebral malaria, and beyond.Immunomodulatory therapy for severe influenza.The amazing innate immune response to influenza A virus infection.Classification and analysis of a large collection of in vivo bioassay descriptions.Statins, fibrates, thiazolidinediones and resveratrol as adjunctive therapies in sepsis: could mitochondria be a common target?Cholesterol is required for stability and infectivity of influenza A and respiratory syncytial viruses.The Flavonoid Isoliquiritigenin Reduces Lung Inflammation and Mouse Morbidity during Influenza Virus Infection.The inflammatory response triggered by Influenza virus: a two edged sword.Cholesterol reducing agents inhibit assembly of type I parainfluenza viruses.Opposing Effects of Fasting Metabolism on Tissue Tolerance in Bacterial and Viral InflammationGenetic screens for the control of influenza virus replication: from meta-analysis to drug discovery.Report of the 'mechanisms of lung injury and immunomodulator interventions in influenza' workshop, 21 March 2010, Ventura, California, USA.The role of adjuvant immunomodulatory agents for treatment of severe influenza.
P2860
Q24616614-24E8C8E2-F0F9-421D-A4B7-09B24C5E8728Q26800158-FCD0ABB4-3897-4CBE-9764-119D0E031737Q28084005-4BD15ADE-88A8-4AB4-B40C-44A04A5F7FBCQ30228213-D5400AD0-43FB-408E-A8CC-4A79EDDBAC72Q30243907-02EEB378-3784-4FC7-A5D9-D2FDE64F114DQ30355446-F3A04F38-A194-4BCC-A8E5-E6CDE7782D01Q30374306-57697E3D-E0A1-4A68-AFCF-3F40628E2FDBQ30375026-5EF63C5F-72DE-4CA2-9F69-DC014124832EQ30379206-C187EE8B-B392-4E7A-BE57-E4DF0D1B4783Q30391218-74F90706-8B38-43E2-8440-7073A1E9E17AQ30392708-2768F84B-7708-4EC3-8A68-35A940FD365CQ30401138-5C9AA5E9-349B-4CB0-9DBF-F76BE8D10663Q30401260-084AC9D2-C6F4-431B-8806-148837AEF849Q30426929-321361AD-C514-4E0E-92B2-28F02E625032Q30456363-C4CA66F1-A6AA-463E-97B3-BD7E77B44C45Q30482353-56FC2EC4-6A61-4AFA-9A1F-D5EA4E3BD97BQ33591243-01B5B675-C08D-41C9-B95D-1B202D674A6AQ33941922-9D7827A2-6D34-41C1-85E8-D22D241D7F26Q34894660-2D9ABC97-6B59-435E-A0D4-D5DE93A68F14Q35154023-5138213C-AE2A-4B2D-9E32-079F871A2ABBQ35453774-1D632130-7952-4171-A8F3-97B5BDAA80CBQ35804633-8241D02C-DDDC-498E-B29E-1F1AD53A72A5Q36018677-93624356-F965-49F1-9B66-86B35069941FQ36459143-24F28829-B376-4891-AA75-3B1A69339377Q36487304-8DF73027-9BD7-409C-82AD-163844FEB601Q36607954-95BB298D-BBD0-46B5-8914-C49C3383A598Q37086826-C131C43C-3B1C-4EB3-B9B8-41E0176FFC93Q37486876-3A1B51FA-409E-4D2A-BD81-3CFF2969CD75Q37910249-7B04BC7B-8EFD-412B-B8EB-A39AECE854A3Q38161762-936E97CB-1B3F-442A-9722-FAF168373270Q38374528-17480991-10AC-4A7C-9B8E-C0C170300246Q38565307-9631CEE2-AB0C-41BC-AFF9-FA54F63CD8BBQ38657280-BFA188C8-2A25-4472-BD75-69BBABF4D2ABQ38845861-6099BB2E-750D-496B-AC95-BE745E5C1F97Q38981754-38808B4D-7DB3-4BDC-A8D7-A2552ABD7119Q40424878-5B1DD78A-F6C5-4DEF-8CF6-73210E6F3AD1Q40545879-B6D461C8-6EB6-4327-9BF2-D562525DEE61Q45359885-A9E5076F-59FB-441D-9FB2-AC067912AD93Q46139825-298FE00A-18CC-4F5F-A4EF-43ABEC6166E2Q47554935-DA3A7702-AFD8-4B30-88B4-1AF095DB53EE
P2860
Increased survival after gemfibrozil treatment of severe mouse influenza.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Increased survival after gemfibrozil treatment of severe mouse influenza.
@ast
Increased survival after gemfibrozil treatment of severe mouse influenza.
@en
type
label
Increased survival after gemfibrozil treatment of severe mouse influenza.
@ast
Increased survival after gemfibrozil treatment of severe mouse influenza.
@en
prefLabel
Increased survival after gemfibrozil treatment of severe mouse influenza.
@ast
Increased survival after gemfibrozil treatment of severe mouse influenza.
@en
P2093
P2860
P356
P1476
Increased survival after gemfibrozil treatment of severe mouse influenza.
@en
P2093
Alison Budd
Arno Müllbacher
Aulikki Koskinen
Lisa Alleva
Mohammed Alsharifi
Victoria Smythe
P2860
P304
P356
10.1128/AAC.00219-07
P407
P577
2007-06-11T00:00:00Z